Link to this page

Your search term(s) "diabetic neuropathy" returned 129 results.

Page 1 2 3 4 5 6 7 8 9 10 11 12 13    Display All

Diabetes Skin And Foot Care: In Step. 4th ed. Timonium, MD: Milner-Fenwick. 2008. (DVD).

This DVD program reviews the importance of skin and foot care for people who have diabetes. The program describes practical suggestions for maintaining healthy skin and feet, how to check for problems, appropriate footwear, and how to work in tandem with a health care provider to minimize any complications. The program depicts the use of the monofilament test that is used to detect diabetic neuropathy or nerve disease, particularly in the extremities. Viewers are reminded of the importance of a self-management plan for keeping diabetes under control and preventing or minimizing these complications with good blood glucose control. The video depicts a variety of people who share their experiences with diabetes management and self-care. Simple graphics are used to explain most of the topics covered. Viewers are referred to the American Association of Diabetes Educators website for more information and to find a local diabetes educator.

Full Record   Printer Friendly Version

How to Keep Your Feet: Avoiding Peripheral Vascular Disease. Diabetes Forecast. 61(2): 50-51. February 2008.

This article reminds readers of the importance of careful foot care in people with diabetes. The author describes peripheral vascular disease (PVD), the cardiovascular complication of diabetes that contributes to foot problems, and diabetic neuropathy, nerve damaged caused by high blood glucose levels. The first warning sign of danger to the feet is usually an ulcer, which can lead to one of the most feared complications of diabetes: amputation of a foot or leg. The author reviews some of the steps to a thorough physical examination that should be performed by the health care provider each time a patient with diabetes comes in for a check-up. The article describes the Ankle-Brachial Index (ABI), a simple test measuring the balance between the blood pressure in the arms and the feet, which can be an important indication of problems associated with vascular disease. One sidebar emphasizes the importance of quitting smoking immediately because the greatest risk of PVD and foot amputation is in people with diabetes who smoke cigarettes. 2 figures.

Full Record   Printer Friendly Version

Microvascular And Macrovascular Complications of Diabetes. Clinical Diabetes. 26(2): 77-82. Spring 2008.

This article is part of a 12-part series for physicians in training that reviews the fundamentals of diabetes care; this article summarizes the microvascular and macrovascular complications of the disease. The author emphasizes the importance of protecting the body from hyperglycemia, the complications of which are the major source of morbidity and mortality from both type 1 and type 2 diabetes. The article discusses the microvascular complications, including diabetic retinopathy, diabetic nephropathy, and diabetic neuropathy. The article outlines the macrovascular complications of diabetes, notably the increased risk of cardiovascular diseases. Readers are reminded of the importance of monitoring their patients for these complications, implementing therapies that counter hyperglycemia, using drug therapies and lifestyle changes to manage hypertension, and regularly measuring blood pressure and blood glucose levels. Recommendations for various monitoring and screening tests are also provided. 39 references.

Full Record   Printer Friendly Version

Prevent Diabetes Problems: Keep Your Nervous System Healthy. Bethesda, MD: National Diabetes Information Clearinghouse. 2008. 27 p.

Diabetes is a disease in which blood glucose levels are above normal. People who have diabetes often experience complications due to these high blood glucose levels, including in the heart, blood vessels, eyes, and kidneys. This booklet, written in nontechnical language, answers common questions about nerve problems that can be caused by diabetes. Topics covered include daily activities that can help a person with diabetes stay healthy; foot care; the physiology of the nervous system; how diabetes can affect the peripheral, autonomic, and cranial nerves; the symptoms of nerve damage; and where to get additional information about diabetes nerve problems, including the contact information for resource organizations. The booklet concludes with a section that briefly summarizes the activities of the National Diabetes Information Clearinghouse (NDIC). The booklet is illustrated with black-and-white line drawings and includes a brief pronunciation guide for some of the medical terms used. 14 figures.

Full Record   Printer Friendly Version

Preventing Long Term Complications of Diabetes. 4th ed. Timonium, MD: Milner-Fenwick. 2008. (DVD).

This DVD program explains the long-term complications of diabetes, including atherosclerosis and other cardiovascular diseases, kidney disease, eye disease, and neuropathy. Viewers are reminded of the importance of a self-management plan for keeping diabetes under control and preventing or minimizing these complications. The management plan outlined includes patient education, healthy eating, physical activity and exercise, medications, self-monitoring of blood glucose (SMBG), and the glycosylated hemoglobin (A1C) test used for longer term monitoring of blood glucose levels. The video depicts a variety of people who share their experiences with complications and diabetes management. Simple graphics are used to explain most of the topics covered. Viewers are referred to the American Association of Diabetes Educators website for more information and to find a local diabetes educator.

Full Record   Printer Friendly Version

Treatment of Diabetic Neuropathy and Neuropathic Pain: How Far Have We Come?. Diabetes Care. 31(Suppl 2): S255-S261. February 2008.

This article explores the current and proposed treatment of diabetic neuropathy and neuropathic pain, common complications in people with diabetes. Treatment is based on four components: causal treatment aimed at achieving normal blood glucose levels; treatment based on pathogenetic mechanisms; symptomatic treatment; and avoidance of risk factors and complications. Because the pathogenesis of diabetic neuropathy is multifactorial, treatments must use different approaches. The authors review some of the new treatments being evaluated in clinical trials, including alpha-lipoic acid and epalrestat, which are already available in some countries. Some new analgesic drugs have been recently approved in the United States, including duloxetine and pregabalin, but the pharmacologic treatment of chronic painful diabetic neuropathy remains a challenge for the physician and patient. Risk factors that can contribute to painful diabetic neuropathy including alcohol consumption, as well as traditional cardiovascular risk factors such as hypertension, smoking, and cholesterol; these factors need to be prevented or treated to help patients coping with diabetic neuropathy. 3 tables. 43 references.

Full Record   Printer Friendly Version

Aldose Reductase Inhibitors for the Treatment of Diabetic Neuropathy. IN: Veves, A.; Malik, R.A., eds. Diabetic Neuropathy: Clinical Management. 2nd ed. Totowa, NJ: Humana Press. 2007. pp 309-320.

This chapter on the use of aldose reductase inhibitors (ARIs) for the treatment of diabetic neuropathy is from a comprehensive textbook that provides general practitioners details on the latest techniques for the clinical management of this diabetes complication. The author notes that despite the initial encouraging results from both animal and human studies, ARIs have not been established for the treatment of diabetic neuropathy. The main reasons they are not yet recommended are inconsistent results and the unacceptably high rate of side effects that are associated with the initially tested ARIs. The lack of well-defined endpoints and the inability to produce an inhibitor that achieves satisfactory tissue penetration and enzyme inhibition are other contributing factors for this failure. The author reviews clinical trials that have examined the effect of ARIs on human diabetic neuropathy. Specific drugs discussed include alrestatin, sorbinil, ponalrestat, tolrestat, zenarestat, fidarestat, and zopolrestat. 1 table. 31 references.

Full Record   Printer Friendly Version

Cardiovascular Autonomic Neuropathy. IN: Veves, A.; Malik, R.A., eds. Diabetic Neuropathy: Clinical Management. 2nd ed. Totowa, NJ: Humana Press. 2007. pp 389-412.

This chapter on cardiovascular autonomic neuropathy (CAN) is from a comprehensive textbook that provides general practitioners details on the latest techniques for the clinical management of diabetic neuropathy. The author notes that CAN is a common but frequently overlooked complication of diabetes. The clinical manifestations of CAN cover a spectrum of symptoms ranging from mild exercise intolerance to sudden cardiac death. The chapter reviews the clinical importance of CAN in diabetes, with a particular focus on its impact on the heart. Topics include epidemiology, the natural history of CAN, methods of assessment and diagnostic approaches, the clinical implications and patient management, and treatment strategies. New imaging techniques have shown that cardiac dysinnervation can occur early in the course of diabetes and can rapidly progress in patients with poor metabolic control. Recent studies have highlighted the role of cardiac dysinnervation in the development of altered myocardial blood flow regulation, impaired left ventricular function, and possibly in the development of diabetic cardiomyopathy. Treatment is based primarily on management of a number of modifiable risk factors; no definitive treatment for reversing CAN has yet been established. 3 figures. 2 tables. 171 references.

Full Record   Printer Friendly Version

Chronic Complications of Diabetes. IN: Scobie, I.N. Atlas of Diabetes Mellitus. 3rd ed. New York, NY: Informa Healthcare USA. 2007. pp 69-108.

This chapter about the chronic complications of diabetes is from an atlas of diabetes mellitus that offers text and pictures to familiarize clinicians with the most current information about diabetes and its diagnosis and treatment. The volume portrays the wide and varied expressions of diabetes and its complications as an aid to their more ready recognition in clinical practice. This chapter discusses the symptoms, prevalence, pathology, prognosis, and management of diabetic retinopathy, diabetic nephropathy, diabetic neuropathy, major vascular disease, hypertension, the diabetic foot, erectile dysfunction, nonalcoholic steatohepatitis, skin disorders, and rare manifestations, including diabetic cheiroarthropathy, Dupuytren’s contracture, and adhesive capsulitis of the shoulder. The chapter offers full-color photographs and figures representing examples of each of these same topics. The photographs have brief captions that focus on clinical treatment for the problem depicted. 5 figures. 71 references.

Full Record   Printer Friendly Version

Clinical Diagnosis of Diabetic Neuropathy. IN: Veves, A.; Malik, R.A., eds. Diabetic Neuropathy: Clinical Management. 2nd ed. Totowa, NJ: Humana Press. 2007. pp 275-292.

This chapter on the clinical diagnosis of diabetic neuropathy is from a comprehensive textbook that provides general practitioners details on the latest techniques for the clinical management of this diabetes complication. The authors stress that the clinical assessment of diabetic neuropathies typically involves evaluation of both subjective symptoms and neurological deficits; an alteration in the former does not necessarily reflect an improvement in nerve function. The authors discuss clinical screening devices including the Semmes-Weinstein monofilament, graduated Rydel-Seiffer tuning fork, tactile circumferential discriminator, and Neuropen; other techniques discussed include quantitative sensory testing, electrophysiology, amplitude, F waves, distribution of velocities, the axon reflex, nerve biopsy, skin biopsy, magnetic resonance imaging (MRI), corneal confocal microscopy, and assessing risk of ulceration. The authors conclude that recent advances have included improved treatments for painful diabetic neuropathies, but treatment for the underlying pathology is still lacking. 3 figures. 4 tables. 66 references.

Full Record   Printer Friendly Version

Page 1 2 3 4 5 6 7 8 9 10 11 12 13    Display All

Start a new search.